Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Invitation to offer for NHS National Pharmaceuticals Transition 2022_1
Offer reference number: CM/PHG/21/5637
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.
Potential periods of call-offs under the framework agreement:
Transition: CESW: 29/07/2022 to 30/09/2023 (14 months)
LSNE: 29/07/2022 to 31/05/2024 (22 months)
NWLN: 29/07/2022 to 31/01/2023 (6 months)
Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months)
Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months)
LSNE: 29/07/2022 to 31/05/2024 (22 months)
NWLN: 29/07/2022 to 31/01/2023 (6 months)
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Accord-UK Ltd | 00079585 | ~£79,272,690 estimated from lot values | - |
| Alturix | 10994664 | ~£79,272,690 estimated from lot values | - |
| Amarox Limited | 10997632 | ~£79,272,690 estimated from lot values | - |
| Aspen Pharmacare UK Limited | 11411661 | ~£79,272,690 estimated from lot values | - |
| B. Braun Medical Limited | 02296559 | ~£79,272,690 estimated from lot values | - |
| Celix Pharma Ltd. | 12474195 | ~£79,272,690 estimated from lot values | - |
| Chiesi Limited | 02140985 | ~£79,272,690 estimated from lot values | LOBBYIST Ovid Consulting Ltd (7 quarters) Hill & Knowlton Limited (4 quarters) Portland PR Limited (2 quarters) |
| Clinigen Healthcare Limited | 06252720 | ~£79,272,690 estimated from lot values | - |
| Consilient Health Ltd | 05427634 | ~£79,272,690 estimated from lot values | - |
| Day Lewis Medical Ltd | 01904504 | ~£79,272,690 estimated from lot values | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£79,272,690 estimated from lot values | - |
| ennogen healthcare ltd | 07809880 | ~£79,272,690 estimated from lot values | - |
| Flexipharm Austrading Limited | 11368401 | ~£79,272,690 estimated from lot values | - |
| FLYNN PHARMA LTD | FC018156 | ~£79,272,690 estimated from lot values | - |
| Fresenius Kabi Limited | 02182135 | ~£79,272,690 estimated from lot values | - |
| Glenmark Pharmaceuticals Europe Limited | 05040260 | ~£79,272,690 estimated from lot values | - |
| Intrapharm Laboratories Ltd | 03393686 | ~£79,272,690 estimated from lot values | - |
| Kent Pharma Ltd | - | ~£79,272,690 estimated from lot values | - |
| Macure Pharma ApS | - | ~£79,272,690 estimated from lot values | - |
| medac Pharma LLP | OC415849 | ~£79,272,690 estimated from lot values | - |
| Mercury Pharmaceuticals Limited | 02619880 | ~£79,272,690 estimated from lot values | - |
| Milpharm Ltd/aurobinbdo | - | ~£79,272,690 estimated from lot values | - |
| Morningside Pharmaeuticals | - | ~£79,272,690 estimated from lot values | - |
| Mylan | 05460854 | ~£79,272,690 estimated from lot values | - |
| Napp Pharmaceuticals Ltd | 03690299 | ~£79,272,690 estimated from lot values | - |
| Neon Healthcare Ltd | 06844351 | ~£79,272,690 estimated from lot values | - |
| Norgine Pharmaceuticals Limited | 03527131 | ~£79,272,690 estimated from lot values | - |
| Panpharma UK Limited | 09519853 | ~£79,272,690 estimated from lot values | - |
| Pfizer Ltd | 00526209 | ~£79,272,690 estimated from lot values | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Piramal Critical care Limited | 05160306 | ~£79,272,690 estimated from lot values | - |
| Ranbaxy UK | - | ~£79,272,690 estimated from lot values | - |
| Relonchem Ltd | 04773758 | ~£79,272,690 estimated from lot values | - |
| Roche Products Ltd | 00100674 | ~£79,272,690 estimated from lot values | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Roma Pharmaceuticals Limited | 10217518 | ~£79,272,690 estimated from lot values | - |
| Rosemont Pharmaceuticals Limited | 00924648 | ~£79,272,690 estimated from lot values | - |
| Sandoz Ltd | 01547204 | ~£79,272,690 estimated from lot values | - |
| Selective Supplies Ltd. | 03794482 | ~£79,272,690 estimated from lot values | - |
| Sintetica Ltd | 09949693 | ~£79,272,690 estimated from lot values | - |
| Teva UK Limited | 00302461 | ~£79,272,690 estimated from lot values | - |
| Tillomed Laboratories ltd | 02544103 | ~£79,272,690 estimated from lot values | - |
| Wockhardt UK Limited | 05835570 | ~£79,272,690 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£79,272,690 estimated from lot values | - |
Government spending data: These suppliers have received £1,159,268,630 in 7,709 payments (over £25k) from NHS Supply Chain (DHSC-funded), UK Health Security Agency, Department of Health and Social Care, NHS England, Manchester University NHS Foundation Trust and 18 more public bodies (2010-04-16 to 2026-03-31).